System for Detecting an Intraoral Disease and Determining a Personalized Treatment Scheme and Method of Doing Same

A system for providing a personalized oral care formulation for a patient, said system comprising:

• a. a detection module for detecting in vitro at least one of oral bacterial, viral and/or fungal infection in a sample of oral cavity obtained from said patient;
• b. an in vitro test module for testing antibacterial, antiviral and/or antifungal activity of a panel comprising antimicrobial, antiviral, antifungal compounds or combinations thereof,
• the detection module and the in vitro test module being separated or combined in the same module;
• and
• c. an oral care compounding module for receiving data from said in vitro test module concerning effectiveness of compounds comprised in said panel on at least one of antibacterial, antiviral and/or antifungal activity in said patient's sample;
• wherein said oral care compounding module provides instructions on producing an oral care formulation comprising at least one antimicrobial, antiviral and/or antifungal compound comprised in said panel having a more effective antibacterial, antiviral and/or antifungal activity in vitro compared to other antimicrobial, antiviral or antifungal compounds.

A method for providing a patient a personalized oral care formulation, the method comprising steps of:

• a. obtaining a sample from an oral cavity of said patient;
• b. incubating said sample in vitro for detecting at least one of oral bacterial, viral or fungal infection;
• c. in vitro testing antibacterial, antiviral and/or antifungal activity of a panel comprising at least one of antimicrobial, antiviral and/or antifungal compounds, or combination thereof, the incubating and the testing, steps, (b) and (c), being separate steps or combined in the same step;
• and
• d. receiving data from said in vitro test concerning effectiveness of at least one compound comprised in said panel on at least one of antibacterial, antiviral, or antifungal activity in said patient's sample;
• e. providing instructions on producing an oral care formulation comprising at least one antimicrobial, antiviral or antifungal compound comprised in said panel having a more effective antibacterial, antiviral and/or antifungal activity in vitro compared to other antimicrobial, antiviral or antifungal compounds;
• and
• f. administering the oral care formulation to said patient.